Stay updated on TROPION-Lung02 Phase 1 Clinical Trial
Sign up to get notified when there's something new on the TROPION-Lung02 Phase 1 Clinical Trial page.

Latest updates to the TROPION-Lung02 Phase 1 Clinical Trial page
- Check3 days agoChange DetectedDifference0.4%

- Check10 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a small update to the page's template or underlying system. This maintenance release does not alter the visible content.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe study design now uses a single-group assignment instead of sequential assignment. Dose escalation and expansion occur within that single group.SummaryDifference0.4%

- Check53 days agoChange DetectedClinicalTrials.gov’s page revision/version indicator was updated from **v3.5.2** to **v3.5.3**, with no change to the underlying study information shown on the page.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check82 days agoChange DetectedA Publications section was added, including a citation to Levy B et al. Datopotamab Deruxtecan Plus Pembrolizumab in NSCLC (J Thorac Oncol, 2026). The entry is automatically populated from PubMed and may not be directly about the study.SummaryDifference0.2%

Stay in the know with updates to TROPION-Lung02 Phase 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TROPION-Lung02 Phase 1 Clinical Trial page.